Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-07

Clinical Trial Update: Comparison Between a 1L of Polyethylene Glycol+Ascorbic Acid as a Split Dose Bowel Preparation for Colonoscopy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing a split-dose bowel preparation (polyethylene glycol+ascorbic acid) for colonoscopy; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene Glycol+Ascorbic Acid

Snippet

Sponsor: Seoul National University Hospital | Conditions: Colon Adenoma, Colonic Polyp | Phase 4 | Status: UNKNOWN